Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
Roger S. McIntyre
Neuropsychiatric Disease and Treatment (2017) Vol. Volume 13, pp. 2913-2919
Open Access | Times Cited: 20

Showing 20 citing articles:

Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis
April Slee, Irwin Nazareth, Paulina Bondaronek, et al.
The Lancet (2019) Vol. 393, Iss. 10173, pp. 768-777
Open Access | Times Cited: 306
The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
Bing Cao, Caroline Park, Mehala Subramaniapillai, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 99
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
Roger S. McIntyre, Henrik Loft, Michael Cronquist Christensen
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 575-585
Open Access | Times Cited: 59
Antidepressant-Like Effects of Cistanche tubulosa Extract on Chronic Unpredictable Stress Rats Through Restoration of Gut Microbiota Homeostasis
Yang Li, Ying Peng, Ping Ma, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 60
Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis
Bach Xuan Tran, Giang Hai Ha, Giang Thu Vu, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 13, pp. 2255-2255
Open Access | Times Cited: 38
Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studies
Gregory W. Mattingly, Oscar Necking, Simon Nitschky Schmidt, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 4, pp. 613-619
Open Access | Times Cited: 11
Pharmacokinetics and Pharmacodynamics: A Comprehensive Analysis of the Absorption, Distribution, Metabolism, and Excretion of Psychiatric Drugs
Zainab Zakaraya, Mohammad Abu Assab, Lina Tamimi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 280-280
Open Access | Times Cited: 3
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
Daniela Adamo, Elena Calabria, Noemi Coppola, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 18
Vilazodone Alleviates Neurogenesis-Induced Anxiety in the Chronic Unpredictable Mild Stress Female Rat Model: Role of Wnt/β-Catenin Signaling
Rana A. El‐Kadi, Noha F. Abdelkader, Hala F. Zaki, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 9060-9077
Open Access | Times Cited: 2
Antidepressant-like effect of a selenopropargylic benzamide in mice: involvement of the serotonergic system
Evelyn Mianes Besckow, Natália Tavares Nonemacher, Cleisson Schossler Garcia, et al.
Psychopharmacology (2020) Vol. 237, Iss. 10, pp. 3149-3159
Closed Access | Times Cited: 19
Effects of Vortioxetine on depression model rats and expression of BDNF and Trk B in hippocampus
Baomin Sun, Yanhua Lv, Hua Xu, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 16
Effectiveness, tolerability, and dropout rates of vortioxetine in comorbid depression: A naturalistic study
Vera De Carlo, Matteo Vismara, Benedetta Grancini, et al.
Human Psychopharmacology Clinical and Experimental (2020) Vol. 35, Iss. 5
Open Access | Times Cited: 12
The efficacy of levomilnacipran ER across symptoms of major depressive disorder: a post hoc analysis of 5 randomized, double-blind, placebo-controlled trials
Roger S. McIntyre, Carl Gommoll, Changzheng Chen, et al.
CNS Spectrums (2016) Vol. 21, Iss. 5, pp. 385-392
Open Access | Times Cited: 11
New arylpiperazine derivatives with antidepressant-like activity containing isonicotinic and picolinic nuclei: evidence for serotonergic system involvement
Ewa Kędzierska, Ferdinando Fiorino, Elisa Magli, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2019) Vol. 392, Iss. 6, pp. 743-754
Open Access | Times Cited: 10
The dose-response relationship of vortioxetine on major depressive disorder: an umbrella review
Ping Wang, Weiwei Wang, Yiqi Liu, et al.
Psychiatry Research (2024) Vol. 340, pp. 116118-116118
Open Access
Management of Antidepressant Therapy–Induced Sexual Dysfunction in Women
Ann R. Lurati
The Journal for Nurse Practitioners (2022) Vol. 18, Iss. 5, pp. 522-524
Closed Access | Times Cited: 2
The clinical utility of newer antidepressant agents: Understanding the role in management of MDD
Kristin Waters
Mental Health Clinician (2022) Vol. 12, Iss. 5, pp. 309-319
Open Access | Times Cited: 2
Cognitive dysfunction: An important feature of major depressive disorder
Dong-Xiao Duan, Xiaohui Li, Lin Yang, et al.
Neurons and Neurological Disorders (2023) Vol. 2, Iss. 1
Open Access
Vortioxetine for depression: the evidence for its current use in the UK
Riccardo De Giorgi
BJPsych Advances (2018) Vol. 25, Iss. 1, pp. 3-6
Open Access
Sexualidad, Depresión y Antidepresivos. ¿Cómo enfrentar este dilema? Revisión comprensiva del uso de psicofármacos en Trastorno Depresivo Mayor y Sexualidad
Magda Vercellino, Rodolfo Philippi
Revista chilena de neuro-psiquiatría (2020) Vol. 58, Iss. 4, pp. 400-412
Open Access
Page 1

Scroll to top